Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
This produced modest weight loss with minimal side effects
Early trial results In phase 2 trials, Retatrutide delivered impressive results: Mean weight reduction of up to ~17.5% at 24 weeks, rising to ~24.2% at 48 weeks in overweight/obese adults
If retatrutide shows cardiovascular benefit similar to or better than semaglutide, it would significantly strengthen the case for approval and potentially expand the labeled indications
Before recommending peptide therapy, we review your medical history, current symptoms, lifestyle habits, and health goals
Ultimately, the decision to continue or discontinue Wegovy should be made collaboratively with your healthcare provider, weighing the benefits of weight management against any adverse effects on mental wellbeing
US$ 21.57
US$ 26.43
US$ 28.50
US$ 21.43
US$ 20.09
US$ 21.65
US$ 25.93
